PubRank

Gillian A Whalley

Author PubWeight™ 36.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2012 2.29
2 A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis. Am Heart J 2008 2.04
3 Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 2004 1.80
4 The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail 2009 1.63
5 Left ventricular systolic and diastolic function assessed by tissue Doppler imaging and outcome in asymptomatic aortic stenosis. Eur Heart J 2010 1.49
6 Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation. Eur Heart J 2008 1.47
7 Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 2003 1.25
8 A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. Circ Cardiovasc Genet 2010 1.21
9 Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail 2012 1.21
10 Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol 2004 1.18
11 Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J Mol Cell Cardiol 2011 1.17
12 Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail 2009 1.05
13 Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol 2011 1.00
14 Understanding changing patterns of survival and hospitalization for heart failure over two decades in New Zealand: utility of 'days alive and out of hospital' from epidemiological data. Eur J Heart Fail 2010 1.00
15 Left ventricular diastolic filling and systolic function of young and older trained and untrained men. J Appl Physiol (1985) 2003 0.93
16 Redefining normal reference ranges for echocardiography: a major new individual person data meta-analysis. Eur Heart J Cardiovasc Imaging 2012 0.93
17 Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 2012 0.90
18 Survey of clinical echocardiography in New Zealand (SCANZ). N Z Med J 2008 0.88
19 Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease. Circ Cardiovasc Genet 2011 0.87
20 Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail 2013 0.86
21 The effect of type 2 diabetes on diastolic function. Med Sci Sports Exerc 2006 0.85
22 Restrictive filling pattern is a powerful predictor of heart failure events postacute myocardial infarction and in established heart failure: a literature-based meta-analysis. J Card Fail 2007 0.82
23 Pseudonormal mitral filling is associated with similarly poor prognosis as restrictive filling in patients with heart failure and coronary heart disease: a systematic review and meta-analysis of prospective studies. J Am Soc Echocardiogr 2009 0.82
24 Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis. Heart 2006 0.80
25 Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus. Expert Rev Cardiovasc Ther 2008 0.78
26 Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J 2008 0.78
27 Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure. Heart Lung Circ 2006 0.78
28 Community screening for cardiovascular risk factors and levels of treatment in a rural Māori cohort. Aust N Z J Public Health 2011 0.77
29 A cohort study comparing cardiovascular risk factors in rural Maori, urban Maori and non-Maori communities in New Zealand. BMJ Open 2012 0.77
30 Arterial baroreceptor reflex control of renal sympathetic nerve activity following chronic myocardial infarction in male, female, and ovariectomized female rats. Am J Physiol Regul Integr Comp Physiol 2015 0.77
31 Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. J Am Soc Echocardiogr 2007 0.77
32 CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in acute coronary syndrome patients. Clin Exp Pharmacol Physiol 2009 0.77
33 Understanding differences in results from literature-based and individual patient meta-analyses: an example from meta-analyses of observational data. Int J Cardiol 2009 0.76
34 KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients. J Cardiovasc Electrophysiol 2011 0.76
35 The relationship between BNP and E/Ea in patients hospitalized with acute heart failure. Int J Cardiol 2007 0.75
36 Mechanisms of benefit of sustained weight reduction in morbid obesity: beyond reduction in conventional cardiovascular risk factors. J Hypertens 2007 0.75
37 Endothelium-dependent dilatation in patients with type 2 diabetes. Am J Cardiol 2002 0.75
38 Definition of physiological hypertrophy in ultramarathon athletes. J Am Coll Cardiol 2004 0.75
39 Changes in tissue-Doppler echocardiographic assessment of left ventricular filling during NT-proBNP guided heart failure treatment titration: a pilot study. Heart Lung Circ 2008 0.75
40 A comparison of the effects of indexation on standard echocardiographic measurements of the left heart in a healthy multi-racial population. Int J Cardiovasc Imaging 2014 0.75
41 Coming of age: affiliate member profile and participation in the annual scientific meeting of the cardiac society of Australia and New Zealand. Heart Lung Circ 2007 0.75
42 Which cardiovascular risk factors are associated with cardiovascular disease and predict future events in advanced age in New Zealand? Australas J Ageing 2012 0.75
43 Brain natriuretic peptide in the contemporary management of congestive heart failure. Expert Rev Cardiovasc Ther 2005 0.75
44 Prediction of ACC/AHA Stage B heart failure by clinical and neurohormonal profiling among patients in the community. J Card Fail 2010 0.75